A Pharmacokinetic Study Comparing the 14028 Injection and TRULICITY® in Healthy Chinese Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2022

Primary Completion Date

July 2, 2022

Study Completion Date

July 8, 2022

Conditions

Type 2 Diabetes

Interventions

BIOLOGICAL

14028 injection

14028 injection, single dose, s.c. injection

BIOLOGICAL

dulaglutide injection

dulaglutide injection(TRULICITY®), single dose, s.c. injection

Trial Locations (1)

PKUCare Luzhong Hospital, Zibo

All Listed Sponsors

lead

Sunshine Lake Pharma Co., Ltd.

INDUSTRY